578 related articles for article (PubMed ID: 30871626)
1. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.
Courau T; Bonnereau J; Chicoteau J; Bottois H; Remark R; Assante Miranda L; Toubert A; Blery M; Aparicio T; Allez M; Le Bourhis L
J Immunother Cancer; 2019 Mar; 7(1):74. PubMed ID: 30871626
[TBL] [Abstract][Full Text] [Related]
2. CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.
Han Y; Sun F; Zhang X; Wang T; Jiang J; Cai J; Gao Q; Hezam K; Liu Y; Xie J; Wang M; Zhang J
J Cancer Res Clin Oncol; 2019 May; 145(5):1179-1190. PubMed ID: 30778749
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory receptor CD94/NKG2A on CD8
Eugène J; Jouand N; Ducoin K; Dansette D; Oger R; Deleine C; Leveque E; Meurette G; Podevin J; Matysiak T; Bennouna J; Bezieau S; Volteau C; Thomas WEA; Chetritt J; Kerdraon O; Fourquier P; Thibaudeau E; Dumont F; Mosnier JF; Toquet C; Jarry A; Gervois N; Bossard C
Mod Pathol; 2020 Mar; 33(3):468-482. PubMed ID: 31409873
[TBL] [Abstract][Full Text] [Related]
4. Physical Characterization of Colorectal Cancer Spheroids and Evaluation of NK Cell Infiltration Through a Flow-Based Analysis.
Sargenti A; Musmeci F; Bacchi F; Delprete C; Cristaldi DA; Cannas F; Bonetti S; Pasqua S; Gazzola D; Costa D; Villa F; Zocchi MR; Poggi A
Front Immunol; 2020; 11():564887. PubMed ID: 33424829
[TBL] [Abstract][Full Text] [Related]
5. Monalizumab: inhibiting the novel immune checkpoint NKG2A.
van Hall T; André P; Horowitz A; Ruan DF; Borst L; Zerbib R; Narni-Mancinelli E; van der Burg SH; Vivier E
J Immunother Cancer; 2019 Oct; 7(1):263. PubMed ID: 31623687
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells.
Ferrari de Andrade L; Kumar S; Luoma AM; Ito Y; Alves da Silva PH; Pan D; Pyrdol JW; Yoon CH; Wucherpfennig KW
Cancer Immunol Res; 2020 Jun; 8(6):769-780. PubMed ID: 32209637
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.
Giannattasio A; Weil S; Kloess S; Ansari N; Stelzer EH; Cerwenka A; Steinle A; Koehl U; Koch J
BMC Cancer; 2015 May; 15():351. PubMed ID: 25933805
[TBL] [Abstract][Full Text] [Related]
8. Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
Varesano S; Zocchi MR; Poggi A
Front Immunol; 2018; 9():998. PubMed ID: 29867975
[TBL] [Abstract][Full Text] [Related]
9. Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8
Abd Hamid M; Wang RZ; Yao X; Fan P; Li X; Chang XM; Feng Y; Jones S; Maldonado-Perez D; Waugh C; Verrill C; Simmons A; Cerundolo V; McMichael A; Conlon C; Wang X; Peng Y; Dong T
Cancer Immunol Res; 2019 Aug; 7(8):1293-1306. PubMed ID: 31213473
[TBL] [Abstract][Full Text] [Related]
10. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
Kamiya T; Seow SV; Wong D; Robinson M; Campana D
J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
[TBL] [Abstract][Full Text] [Related]
11. Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer.
Ducoin K; Oger R; Bilonda Mutala L; Deleine C; Jouand N; Desfrançois J; Podevin J; Duchalais E; Cruard J; Benlalam H; Labarrière N; Bossard C; Jarry A; Gervois-Segain N
Oncoimmunology; 2022; 11(1):2046931. PubMed ID: 35295095
[TBL] [Abstract][Full Text] [Related]
12. CD8
Chen Y; Xin Z; Huang L; Zhao L; Wang S; Cheng J; Wu P; Chai Y
Front Immunol; 2019; 10():3002. PubMed ID: 32010126
[No Abstract] [Full Text] [Related]
13. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
[TBL] [Abstract][Full Text] [Related]
14. BCMA-targeting Bispecific Antibody That Simultaneously Stimulates NKG2D-enhanced Efficacy Against Multiple Myeloma.
Wang Y; Li H; Xu W; Pan M; Qiao C; Cai J; Xu J; Wang M; Zhang J
J Immunother; 2020; 43(6):175-188. PubMed ID: 32349046
[TBL] [Abstract][Full Text] [Related]
15. NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.
Maccalli C; Pende D; Castelli C; Mingari MC; Robbins PF; Parmiani G
Eur J Immunol; 2003 Jul; 33(7):2033-43. PubMed ID: 12884870
[TBL] [Abstract][Full Text] [Related]
16. MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a Fc-dependent manner.
Du C; Bevers J; Cook R; Lombana TN; Rajasekaran K; Matsumoto M; Spiess C; Kim JM; Ye Z
J Immunother Cancer; 2019 Aug; 7(1):207. PubMed ID: 31387641
[TBL] [Abstract][Full Text] [Related]
17. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer.
Xu X; Rao G; Gaffud MJ; Ding HG; Maki G; Klingemann HG; Groh V; Spies T; Caillat-Zucman S; Gattuso P; Plate J; Prinz RA
J Clin Endocrinol Metab; 2006 Jul; 91(7):2704-12. PubMed ID: 16621903
[TBL] [Abstract][Full Text] [Related]
19. CD16
Frazao A; Messaoudene M; Nunez N; Dulphy N; Roussin F; Sedlik C; Zitvogel L; Piaggio E; Toubert A; Caignard A
Cancer Immunol Res; 2019 Feb; 7(2):208-218. PubMed ID: 30514793
[TBL] [Abstract][Full Text] [Related]
20. NKG2D Immunoligand rG7S-MICA Enhances NK Cell-mediated Immunosurveillance in Colorectal Carcinoma.
Wang T; Sun F; Wang Y; Jiang J; Pan M; Yuan M; Zhang H; Du X; Hezam K; Song K; Wang M; Zhang J
J Immunother; 2018 Apr; 41(3):109-117. PubMed ID: 29528990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
